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Background. Huntington disease (HD) is an incurable, adult-onset, autosomal dominant 
inherited disorder associated with cell loss within a specific subset of neurons in the basal 
ganglia and cortex. HD is named after George Huntington, the physician who described it as 
hereditary chorea in 1872. Characteristic features of HD include involuntary movements, 
dementia, and behavioral changes.   
Case report.  Purpose and objectives: This study focuses on the variability of the HTT gene 
expression and its correlation with the onset of the disease. It also outlines the genetic aspects 
of the disease: types of inheritance, anticipation and the frequency of new mutations in the 
population. Etiology: The selective neuronal dysfunction and subsequent loss of neurons in the 
striatum, cerebral cortex, and other parts of the brain can explain the clinical picture seen in 
cases of HD. Several mechanisms of neuronal cell death have been proposed for HD, including 
excitotoxicity, oxidative stress, impaired energy metabolism, and apoptosis.  Treatment: In a 
study published recently in the New England Journal of Medicine, researchers from UBC and 
their colleagues have demonstrated for the first time that the drug IONIS-HTTRX (now known 
as RO7234292) successfully lowered the levels of the mutant huntingtin protein - the toxic 
protein that causes Huntington disease -- in the central nervous system of patients. The 
treatment is designed to silence the gene. On the trial, 46 patients had the drug injected into 
cerebrospinal fluid. The first in-human trial showed the drug was safe, well tolerated by 
patients and crucially reduced the levels of huntingtin in the brain.  Experts say it could be the 
biggest breakthrough in neurodegenerative diseases for 50 years. 
Conclusion. Taking into consideration the above description of the new trial treatment of the 
disease, the studies made in this field could be crucial for the next generations.   
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Background. Marfan syndrome (MFS) is an autosomal dominant disorder caused by a 
mutation in FBN1 gene which involves abnormal connective tissue. MFS affects different parts 
of the body such as bones, joints and eyes, but the most serious complication involves 
cardiovascular system. Acute aortic dissection (AD) is a life-threatening condition caused by a 
tear in the intimal layer of the aorta or bleeding within the aortic wall, resulting in the separation 
of the layers of the aortic wall. Even though AD is a characteristic complication of the MFS, 
recurrent aortic dissection (RAD) is a rare phenomenon where MFS is a strong independent 
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risk factor. As many as 15% of aortic dissections are painless and often the signs on 
presentation are subtle and easily overlooked, RAD require a multidisciplinary approach and a 
complex treatment strategy.  
Case report. We present the case of a 47-year old female with a history of MFS since 1976, 
admitted for retrosternal chest pain worsening with activity, associated with shortness of breath 
and radiation of the pain over the abdominal area, for over a month. Her pathological 
background included: aortic dissection (ascending and descending thoracic aorta) in 2005, 
dilated cardiomyopathy, stage 3 hypertension, class IV NYHA chronic heart failure and 
superior and inferior vena cava thrombosis. The transthoracic echocardiography revealed an 
intimal flap and two lumina were visualized in the thoracic aorta under the origin of the left 
subclavian artery (LSA), bicuspid valve with severe aortic regurgitation, tricuspid insufficiency 
and a left atrial appendage thrombus. The thoraco-abdominopelvic CT has exposed an aortic 
dissection involving both the ascending and the descending aorta (Stanford A/DeBakey I). 
Under both medical and surgical treatment consisting in valvuloplasty and angioplasty the 
patient evolution was improving.  
Conclusions. RAD remains a challenging entity regarding both the diagnosis and management, 
but its incidence at patients with MFS may be reduced by regular clinical examination, 
screening and by imaging at the time of diagnosis and during follow-up.  
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Background. Rendu-Osler disease is a rare genetic disease, with suggestive clinical manifestations: 
recurrent epistaxis, telangiectasias and visceral vascular abnormalities. 
Case report. A 40-year-old patient presents to the emergency room for asthenia, dyspnea, recurrent 
epistaxis and headache. Patient’s history revealed that her mother and aunt died from a liver disease 
and the two also presented epistaxis. At the physical examination, pallor, discrete edemas, tachycardia 
and systolic murmur were noticed. Biologically, there was an iron deficiency anemia. The ENT 
examination revealed a vegetative nasal septum formation, which was biopsied. Abdominal 
ultrasound revealed a hypoechogenic formation, in the proximity of the pancreas tail, for which 
angioCT was performed, describing several splenic aneurysms and a particular aspect of hepatic 
vascularization. This pattern is suggestive for intrahepatic arteriovenous malformations. For the 
differential diagnosis: bacterial endocarditis, cirrhosis, connective tissue disease or vasculitis were 
taken into consideration. Resumption of the clinical examination allowed the discovery of a small 
telangiectasia of the upper lip. Based on the Curacao criteria, the diagnosis was established (3 out of 
4: epistaxis, telangiectasia and a positive family history of a relative of the first degree). Further 
investigations were made in order to detect other possible abnormalities. Signs of pulmonary 
hypertension and heart failure were identified, complications secondary to the liver arteriovenous 
malformations. The patient received treatment with iron, initially parenterally, later orally. Selective 
embolization of the largest of the splenic artery aneurysms was performed, taking into account the 
risk of rupture. Iron therapy was maintained as a primary treatment. The patient is monitored 
biannually for the liver and heart disease. Screening for the family members was recommended. 
